Cognitive enhancers: consumption of psychostimulants in medicine
Psychostimulants are drugs that can be used to improve cognitive performance by students and health care professionals. This trend might establish a public health issue. The purpose of this study is to describe the prevalence of psychostimulant use in medical students and resident doctors, and to id...
- Autores:
-
Latella, Andres
Sanchez de Paz, María Pilar
Mata-Suarez, Santiago Miguel
Bignone, Inés
Lerman, Damián
Rojas, Galeno
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2022
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/10141
- Acceso en línea:
- https://hdl.handle.net/11323/10141
https://repositorio.cuc.edu.co/
- Palabra clave:
- Psychostimulants
Drugs
Pharmacoepidemiology
Modafinil
Medical students
Psicoestimulantes
Fármacos
Farmacoepidemiología
Modafinilo
Estudiantes de medicina
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
id |
RCUC2_9defe43c4e1344d0a97656eb7e38f81c |
---|---|
oai_identifier_str |
oai:repositorio.cuc.edu.co:11323/10141 |
network_acronym_str |
RCUC2 |
network_name_str |
REDICUC - Repositorio CUC |
repository_id_str |
|
dc.title.eng.fl_str_mv |
Cognitive enhancers: consumption of psychostimulants in medicine |
dc.title.translated.none.fl_str_mv |
Potenciadores cognitivos: uso de psicoestimulantes en el ámbito de la medicina |
title |
Cognitive enhancers: consumption of psychostimulants in medicine |
spellingShingle |
Cognitive enhancers: consumption of psychostimulants in medicine Psychostimulants Drugs Pharmacoepidemiology Modafinil Medical students Psicoestimulantes Fármacos Farmacoepidemiología Modafinilo Estudiantes de medicina |
title_short |
Cognitive enhancers: consumption of psychostimulants in medicine |
title_full |
Cognitive enhancers: consumption of psychostimulants in medicine |
title_fullStr |
Cognitive enhancers: consumption of psychostimulants in medicine |
title_full_unstemmed |
Cognitive enhancers: consumption of psychostimulants in medicine |
title_sort |
Cognitive enhancers: consumption of psychostimulants in medicine |
dc.creator.fl_str_mv |
Latella, Andres Sanchez de Paz, María Pilar Mata-Suarez, Santiago Miguel Bignone, Inés Lerman, Damián Rojas, Galeno |
dc.contributor.author.none.fl_str_mv |
Latella, Andres Sanchez de Paz, María Pilar Mata-Suarez, Santiago Miguel Bignone, Inés Lerman, Damián Rojas, Galeno |
dc.subject.proposal.eng.fl_str_mv |
Psychostimulants Drugs Pharmacoepidemiology Modafinil Medical students |
topic |
Psychostimulants Drugs Pharmacoepidemiology Modafinil Medical students Psicoestimulantes Fármacos Farmacoepidemiología Modafinilo Estudiantes de medicina |
dc.subject.proposal.spa.fl_str_mv |
Psicoestimulantes Fármacos Farmacoepidemiología Modafinilo Estudiantes de medicina |
description |
Psychostimulants are drugs that can be used to improve cognitive performance by students and health care professionals. This trend might establish a public health issue. The purpose of this study is to describe the prevalence of psychostimulant use in medical students and resident doctors, and to identify consumption related risk factors. The study was conducted through a self-administered, anonymous online survey. 355 respondents were included, 27% (n = 96) were resident doctors, 70.4% (n = 250) students and 2.5% (n = 9) specialists. 17.4% (n = 62) opted for psychostimulant drugs of which modafinil was the most chosen. The most desired effect was to improve wakefulness 83.6% (n = 51). The average age for consumers was 27.31±3.08 (p = 0.033). The multivariate analysis revealed that the predictive variables with highest risk of consumption were: having read the package insert (OR = 5.2; p = 0.0001), previous use of benzodiazepines (OR = 3.75; p = 0.045) and having considered ethical its use (OR=1.03; p = 0.0001). According to literature, the prevalent use of psychostimulants by doctors under training in our population might be higher than other countries. This study is an important source of information for health authorities as it highlights unrestricted access and inappropriate use of psychostimulants. |
publishDate |
2022 |
dc.date.issued.none.fl_str_mv |
2022-01-20 |
dc.date.accessioned.none.fl_str_mv |
2023-05-17T23:30:25Z |
dc.date.available.none.fl_str_mv |
2023-05-17T23:30:25Z |
dc.type.spa.fl_str_mv |
Artículo de revista |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.content.spa.fl_str_mv |
Text |
dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.redcol.spa.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
format |
http://purl.org/coar/resource_type/c_6501 |
status_str |
publishedVersion |
dc.identifier.citation.spa.fl_str_mv |
Latella, A.-N., Sanchez-de-Paz, M.-P., Mata-Suarez, S., Bignone, I., Lerman, D., & Rojas, G. (2022). Cognitive enhancers: Consumption of psychostimulants in medicine. Journal of Applied Cognitive Neuroscience, 2(2), e00233724. https://doi.org/10.17981/JACN.2.2.2021.05 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/11323/10141 |
dc.identifier.doi.none.fl_str_mv |
10.17981/JACN.2.2.2021.05 |
dc.identifier.eissn.spa.fl_str_mv |
2745-0031 |
dc.identifier.instname.spa.fl_str_mv |
Corporación Universidad de la Costa |
dc.identifier.reponame.spa.fl_str_mv |
REDICUC - Repositorio CUC |
dc.identifier.repourl.spa.fl_str_mv |
https://repositorio.cuc.edu.co/ |
identifier_str_mv |
Latella, A.-N., Sanchez-de-Paz, M.-P., Mata-Suarez, S., Bignone, I., Lerman, D., & Rojas, G. (2022). Cognitive enhancers: Consumption of psychostimulants in medicine. Journal of Applied Cognitive Neuroscience, 2(2), e00233724. https://doi.org/10.17981/JACN.2.2.2021.05 10.17981/JACN.2.2.2021.05 2745-0031 Corporación Universidad de la Costa REDICUC - Repositorio CUC |
url |
https://hdl.handle.net/11323/10141 https://repositorio.cuc.edu.co/ |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofjournal.spa.fl_str_mv |
Journal of Applied Cognitive Neuroscience |
dc.relation.references.spa.fl_str_mv |
Barón, L.; Botero-Henao, K.; Castaño Castrillón, J. J.; Castillo-Chang, K.; Díaz-Corrales, J.; Echeverri-Uribe, J. S.; Parra, G. A.; Yepes, J. S.; & Yurgaky-Jordán, H. Y. (2011). Prevalencia y factores asociados al consumo de anfetaminas en estudiantes del Programa de Medicina de la Universidad de Manizales. Revista de la Facultad de Medicina, 59, 201–214. Disponible en https://revistas.unal.edu.co/index.php/revfacmed/article/view/26455 Cakic, V. (2009). Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics, 35(10), 611–615. https://doi.org/10.1136/jme.2009.030882 Dietz, P.; Striegel, H.; Franke, A. G.; Klaus Lieb, K.; Simon, P. & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33(1), 44–50. https://doi.org/10.1002/phar.1166 Eickenhorst, P.; Vitzthum, K.; Klapp, B. F.; Groneberg, D. & Mache, S. (2012). Neuroenhancement Among German University Students: Motives, Expectations, and Relationship with Psychoactive Lifestyle Drugs. Journal of Psychoactive Drugs, 44(5), 418–427. https://doi.org/10.1080/02791072.2012.736845 Fallah, G.; Moudi, S.; Hamidia, A. & Bijani, A. (2018). Stimulant use in medical students and residents requires more careful attention. Caspian Journal of Internal Medicine, 9(1), 87–91. https://doi.org/10.22088/cjim.9.1.87 Franke, A. G.; Bagusat, C.; Rust, S.; Engel, A. & Lieb, K. (2014). Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience, 264(Suppl 1), 83–90. https://doi.org/10.1007/s00406-014-0537-1 Franke, A. G.; Bonertz, C.; Christmann, M.; Huss, M.; Fellgiebel, A.; Hildt, E. & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44(2), 60–66. https://doi.org/10.1055/s-0030-1268417 Froestl, W.; Muhs, A. & Pfeifer, A. (2014a). Cognitive Enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014. Journal of Alzheimers Disease, 41(4), 961–1019. https://doi.org/10.3233/jad-2012-121186 Froestl, W.; Muhs, A. & Pfeifer, A. (2014b). Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 22014. Journal of Alzheimers Disease, 42(1), 1–68. https://doi.org/10.3233/jad-140402 Froestl, W.; Muhs, A. & Pfeifer, A. (2014c). Cognitive Enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014. Journal of Alzheimers Disease, 42(4), 1079–1149. https://doi.org/10.3233/jad-141206 Handel, D. A.; Raja, A. & Lindsell, C. J. (2006). The Use of Sleep Aids among Emergency Medicine Residents: A Web Based Survey. BMC Health Services Research, 6, 1–8. https://doi.org/10.1186/1472-6963-6-136 IBM SPSS Statistics. (version 23.0). Statistical Package for the Social Sciences. [Software]. New York: International Business Machines Corporation. Available: https://www.ibm.com/products/spss-statistics Mache, S.; Eickenhorst, P.; Vitzthum, K.; Klapp, B. F. & Groneberg, D. A. (2012). Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wiener Medizinische Wochenschrift, 162(11-12), 262–271. https://doi.org/10.1007/s10354-012-0115-y Maher, B. (2008). Poll results: look who’s doping. Nature, 452(7188), 674–675. Avaiable: https://www.nature.com/articles/452674a Mazzoglio, M. J.; Algieri, R. D.; Dogliotti, C. B.; Gazzotti, A. M.; Jiménez-Villarruel, H. N. y Rey, L. M. (2011). Utilización de sustancias psicoactivas en alumnos de anatomía y su implicación en el aprendizaje. Educación Médica, 14(2), 129–132. http://dx.doi.org/10.4321/S1575-18132011000200009 McBeth, B. D.; McNamara, R. M.; Ankel, F. K.; Mason, E. J.; Ling, L. J.; Flottemesch, T. J. & Asplin, B. R. (2009). Modafinil and Zolpidem Use by Emergency Medicine Residents. Academic Emergency Medicine, 16(12), 1311–1317. https://doi.org/10.1111/j.1553-2712.2009.00586.x Moore, D. R.; Burgard, D. A.; Larson, R. G. & Ferm, M. (2014). Psychostimulant use among college students during periods of high and low stress: an interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addictive Behaviors, 39(5), 987–993. https://doi.org/10.1016/j.addbeh.2014.01.021 Rojas, G.; Demey, I. & Arizaga, R. L. (2013). Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina. Medicina (B Aires), 73(3), 213–223. Available from https://medicinabuenosaires.com/demo/revistas/vol73-13/3/213-223-med%205968-A.pdf Sánchez, M. P.; Latella, A. N.; Falero, A.; Lerman, D.; Bignone, I. M. I. y Rojas, G. (2021). Análisis de publicidades sobre medicamentos neurológicos recibidos durante la consulta médica. Medicina (B Aires), 81(4), 559–564. Recuperado de https://www.medicinabuenosaires.com/revistas/vol81-21/n4/559.pdf Shy, B. D.; Portelli, I. & Nelson, L. S. (2011). Emergency medicine residents’ use of psychostimulants and sedatives to aid in shift work. The American Journal of Emergency Medicine, 29(9), 1034–1036. https://doi.org/10.1016/j.ajem.2010.06.004 VNM. (s.f.). Vademecum nacional de medicamento. Disponible en http://anmatvademecum.servicios.pami.org.ar/index.html (consultado el 07/10/19). Wolff, W.; Brand, R.; Baumgarten, F.; Lösel, J. & Ziegler, M. (2014). Modeling students’ instrumental (mis-) use of substances to enhance cognitive performance: Neuroenhancement in the light of job demands-resources theory. Biopsychosocial Medicine, 8, 1–11. https://doi.org/10.1186/1751-0759-8-1 Zaami, S.; Rinaldi, R.; Bersani, G.; Del Rio, A.; Ciallella, C. & Marinelli, E. (2020). Nootropics use in the workplace: psychiatric and ethical aftermath towards the new frontier of bioengineering. European Review for Medical and Pharmacological Sciences, 24(4), 2129–2139. https://doi.org/10.26355/eurrev_202002_20393 |
dc.relation.citationendpage.spa.fl_str_mv |
9 |
dc.relation.citationstartpage.spa.fl_str_mv |
1 |
dc.relation.citationissue.spa.fl_str_mv |
2 |
dc.relation.citationvolume.spa.fl_str_mv |
2 |
dc.rights.license.spa.fl_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) |
dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.extent.spa.fl_str_mv |
9 páginas |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Corporación Universidad de la Costa |
dc.publisher.place.spa.fl_str_mv |
Colombia |
dc.source.spa.fl_str_mv |
https://revistascientificas.cuc.edu.co/JACN/article/view/3724 |
institution |
Corporación Universidad de la Costa |
bitstream.url.fl_str_mv |
https://repositorio.cuc.edu.co/bitstreams/7c00d51d-6b23-4816-9d83-a5209890970d/download https://repositorio.cuc.edu.co/bitstreams/e4583f7b-55e3-4205-9f3c-b4b3afe8d454/download https://repositorio.cuc.edu.co/bitstreams/165b8b52-f313-468d-a542-ddca4c986797/download https://repositorio.cuc.edu.co/bitstreams/a45c18ef-4942-4391-b367-d34fe3ffbbae/download |
bitstream.checksum.fl_str_mv |
4ce17268e8fb4fdb3b1fcedba004c017 2f9959eaf5b71fae44bbf9ec84150c7a 5e4c93c382f5d004b26dee87286f29ee ad4811ecfe089c2dcd70e9ebe2baf6cc |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio de la Universidad de la Costa CUC |
repository.mail.fl_str_mv |
repdigital@cuc.edu.co |
_version_ |
1811760671360024576 |
spelling |
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)Copyright (c) 2021 Andres Norberto Latella, María Pilar Sanchez de Paz, Dr., Santiago Mata Suarez, Inés Bignone, Dami´an Lerman, Galeno Rojashttps://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Latella, AndresSanchez de Paz, María PilarMata-Suarez, Santiago MiguelBignone, InésLerman, DamiánRojas, Galeno 2023-05-17T23:30:25Z2023-05-17T23:30:25Z2022-01-20Latella, A.-N., Sanchez-de-Paz, M.-P., Mata-Suarez, S., Bignone, I., Lerman, D., & Rojas, G. (2022). Cognitive enhancers: Consumption of psychostimulants in medicine. Journal of Applied Cognitive Neuroscience, 2(2), e00233724. https://doi.org/10.17981/JACN.2.2.2021.05https://hdl.handle.net/11323/1014110.17981/JACN.2.2.2021.052745-0031Corporación Universidad de la CostaREDICUC - Repositorio CUChttps://repositorio.cuc.edu.co/Psychostimulants are drugs that can be used to improve cognitive performance by students and health care professionals. This trend might establish a public health issue. The purpose of this study is to describe the prevalence of psychostimulant use in medical students and resident doctors, and to identify consumption related risk factors. The study was conducted through a self-administered, anonymous online survey. 355 respondents were included, 27% (n = 96) were resident doctors, 70.4% (n = 250) students and 2.5% (n = 9) specialists. 17.4% (n = 62) opted for psychostimulant drugs of which modafinil was the most chosen. The most desired effect was to improve wakefulness 83.6% (n = 51). The average age for consumers was 27.31±3.08 (p = 0.033). The multivariate analysis revealed that the predictive variables with highest risk of consumption were: having read the package insert (OR = 5.2; p = 0.0001), previous use of benzodiazepines (OR = 3.75; p = 0.045) and having considered ethical its use (OR=1.03; p = 0.0001). According to literature, the prevalent use of psychostimulants by doctors under training in our population might be higher than other countries. This study is an important source of information for health authorities as it highlights unrestricted access and inappropriate use of psychostimulants.Los psicoestimulantes son fármacos que pueden ser utilizados para mejorar el rendimiento cognitivo por los médicos en formación. Esta tendencia representaría un problema de salud pública del cual existe escasa información disponible. Describir la prevalencia del uso de psicoestimulantes en alumnos de medicina y médicos residentes e identificar factores de riesgo asociados al consumo. Encuesta online anónima y autoadministrada. Se analizaron 355 encuestas, 27% (n = 96) fueron médicos residentes, 70.4% (n = 250) estudiantes y 2.5% (n = 9) médicos especialistas. El 17.2% (n = 62) recurrió a drogas psicoestimulantes, de las cuales la más elegida fue el modafinilo (n = 39). El objetivo más buscado fue mejorar la vigilia 83.6% (n = 51). La edad media para los consumidores fue 27.31 ± 3.08 (p = 0.033). En el análisis multivariado se observó que las variables predictoras de mayor riesgo de consumo fueron: haber leído el prospecto (OR = 5.2; p = 0,0001), haber consumido benzodiacepinas previamente (OR = 3.75; p = 0.045) y haber considerado ético su uso (OR = 1.03; p = 0.0001). La prevalencia de uso de psicoestimulantes por médicos en formación en nuestra población podría ser mayor a la de otros países. El presente trabajo representa una importante fuente de información para las autoridades sanitarias dado que destaca el libre acceso y el uso inapropiado de psicoestimulantes.9 páginasapplication/pdfengCorporación Universidad de la CostaColombiahttps://revistascientificas.cuc.edu.co/JACN/article/view/3724Cognitive enhancers: consumption of psychostimulants in medicinePotenciadores cognitivos: uso de psicoestimulantes en el ámbito de la medicinaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Journal of Applied Cognitive NeuroscienceBarón, L.; Botero-Henao, K.; Castaño Castrillón, J. J.; Castillo-Chang, K.; Díaz-Corrales, J.; Echeverri-Uribe, J. S.; Parra, G. A.; Yepes, J. S.; & Yurgaky-Jordán, H. Y. (2011). Prevalencia y factores asociados al consumo de anfetaminas en estudiantes del Programa de Medicina de la Universidad de Manizales. Revista de la Facultad de Medicina, 59, 201–214. Disponible en https://revistas.unal.edu.co/index.php/revfacmed/article/view/26455Cakic, V. (2009). Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics, 35(10), 611–615. https://doi.org/10.1136/jme.2009.030882Dietz, P.; Striegel, H.; Franke, A. G.; Klaus Lieb, K.; Simon, P. & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33(1), 44–50. https://doi.org/10.1002/phar.1166Eickenhorst, P.; Vitzthum, K.; Klapp, B. F.; Groneberg, D. & Mache, S. (2012). Neuroenhancement Among German University Students: Motives, Expectations, and Relationship with Psychoactive Lifestyle Drugs. Journal of Psychoactive Drugs, 44(5), 418–427. https://doi.org/10.1080/02791072.2012.736845Fallah, G.; Moudi, S.; Hamidia, A. & Bijani, A. (2018). Stimulant use in medical students and residents requires more careful attention. Caspian Journal of Internal Medicine, 9(1), 87–91. https://doi.org/10.22088/cjim.9.1.87Franke, A. G.; Bagusat, C.; Rust, S.; Engel, A. & Lieb, K. (2014). Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience, 264(Suppl 1), 83–90. https://doi.org/10.1007/s00406-014-0537-1Franke, A. G.; Bonertz, C.; Christmann, M.; Huss, M.; Fellgiebel, A.; Hildt, E. & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44(2), 60–66. https://doi.org/10.1055/s-0030-1268417Froestl, W.; Muhs, A. & Pfeifer, A. (2014a). Cognitive Enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014. Journal of Alzheimers Disease, 41(4), 961–1019. https://doi.org/10.3233/jad-2012-121186Froestl, W.; Muhs, A. & Pfeifer, A. (2014b). Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 22014. Journal of Alzheimers Disease, 42(1), 1–68. https://doi.org/10.3233/jad-140402Froestl, W.; Muhs, A. & Pfeifer, A. (2014c). Cognitive Enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014. Journal of Alzheimers Disease, 42(4), 1079–1149. https://doi.org/10.3233/jad-141206Handel, D. A.; Raja, A. & Lindsell, C. J. (2006). The Use of Sleep Aids among Emergency Medicine Residents: A Web Based Survey. BMC Health Services Research, 6, 1–8. https://doi.org/10.1186/1472-6963-6-136IBM SPSS Statistics. (version 23.0). Statistical Package for the Social Sciences. [Software]. New York: International Business Machines Corporation. Available: https://www.ibm.com/products/spss-statisticsMache, S.; Eickenhorst, P.; Vitzthum, K.; Klapp, B. F. & Groneberg, D. A. (2012). Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wiener Medizinische Wochenschrift, 162(11-12), 262–271. https://doi.org/10.1007/s10354-012-0115-yMaher, B. (2008). Poll results: look who’s doping. Nature, 452(7188), 674–675. Avaiable: https://www.nature.com/articles/452674aMazzoglio, M. J.; Algieri, R. D.; Dogliotti, C. B.; Gazzotti, A. M.; Jiménez-Villarruel, H. N. y Rey, L. M. (2011). Utilización de sustancias psicoactivas en alumnos de anatomía y su implicación en el aprendizaje. Educación Médica, 14(2), 129–132. http://dx.doi.org/10.4321/S1575-18132011000200009McBeth, B. D.; McNamara, R. M.; Ankel, F. K.; Mason, E. J.; Ling, L. J.; Flottemesch, T. J. & Asplin, B. R. (2009). Modafinil and Zolpidem Use by Emergency Medicine Residents. Academic Emergency Medicine, 16(12), 1311–1317. https://doi.org/10.1111/j.1553-2712.2009.00586.xMoore, D. R.; Burgard, D. A.; Larson, R. G. & Ferm, M. (2014). Psychostimulant use among college students during periods of high and low stress: an interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addictive Behaviors, 39(5), 987–993. https://doi.org/10.1016/j.addbeh.2014.01.021Rojas, G.; Demey, I. & Arizaga, R. L. (2013). Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina. Medicina (B Aires), 73(3), 213–223. Available from https://medicinabuenosaires.com/demo/revistas/vol73-13/3/213-223-med%205968-A.pdfSánchez, M. P.; Latella, A. N.; Falero, A.; Lerman, D.; Bignone, I. M. I. y Rojas, G. (2021). Análisis de publicidades sobre medicamentos neurológicos recibidos durante la consulta médica. Medicina (B Aires), 81(4), 559–564. Recuperado de https://www.medicinabuenosaires.com/revistas/vol81-21/n4/559.pdfShy, B. D.; Portelli, I. & Nelson, L. S. (2011). Emergency medicine residents’ use of psychostimulants and sedatives to aid in shift work. The American Journal of Emergency Medicine, 29(9), 1034–1036. https://doi.org/10.1016/j.ajem.2010.06.004VNM. (s.f.). Vademecum nacional de medicamento. Disponible en http://anmatvademecum.servicios.pami.org.ar/index.html (consultado el 07/10/19).Wolff, W.; Brand, R.; Baumgarten, F.; Lösel, J. & Ziegler, M. (2014). Modeling students’ instrumental (mis-) use of substances to enhance cognitive performance: Neuroenhancement in the light of job demands-resources theory. Biopsychosocial Medicine, 8, 1–11. https://doi.org/10.1186/1751-0759-8-1Zaami, S.; Rinaldi, R.; Bersani, G.; Del Rio, A.; Ciallella, C. & Marinelli, E. (2020). Nootropics use in the workplace: psychiatric and ethical aftermath towards the new frontier of bioengineering. European Review for Medical and Pharmacological Sciences, 24(4), 2129–2139. https://doi.org/10.26355/eurrev_202002_203939122PsychostimulantsDrugsPharmacoepidemiologyModafinilMedical studentsPsicoestimulantesFármacosFarmacoepidemiologíaModafiniloEstudiantes de medicinaPublicationORIGINALCognitive enhancers. Consumption of psychostimulants in medicine.pdfCognitive enhancers. Consumption of psychostimulants in medicine.pdfArtículoapplication/pdf439209https://repositorio.cuc.edu.co/bitstreams/7c00d51d-6b23-4816-9d83-a5209890970d/download4ce17268e8fb4fdb3b1fcedba004c017MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.cuc.edu.co/bitstreams/e4583f7b-55e3-4205-9f3c-b4b3afe8d454/download2f9959eaf5b71fae44bbf9ec84150c7aMD52TEXTCognitive enhancers. Consumption of psychostimulants in medicine.pdf.txtCognitive enhancers. Consumption of psychostimulants in medicine.pdf.txtExtracted texttext/plain29003https://repositorio.cuc.edu.co/bitstreams/165b8b52-f313-468d-a542-ddca4c986797/download5e4c93c382f5d004b26dee87286f29eeMD53THUMBNAILCognitive enhancers. Consumption of psychostimulants in medicine.pdf.jpgCognitive enhancers. Consumption of psychostimulants in medicine.pdf.jpgGenerated Thumbnailimage/jpeg13240https://repositorio.cuc.edu.co/bitstreams/a45c18ef-4942-4391-b367-d34fe3ffbbae/downloadad4811ecfe089c2dcd70e9ebe2baf6ccMD5411323/10141oai:repositorio.cuc.edu.co:11323/101412024-09-16 16:41:25.546https://creativecommons.org/licenses/by-nc-nd/4.0/Copyright (c) 2021 Andres Norberto Latella, María Pilar Sanchez de Paz, Dr., Santiago Mata Suarez, Inés Bignone, Dami´an Lerman, Galeno Rojasopen.accesshttps://repositorio.cuc.edu.coRepositorio de la Universidad de la Costa CUCrepdigital@cuc.edu.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 |